The Journal of Immunology, Vol 148, Issue 10 3152-3157, Copyright © 1992 by American Association of Immunologists

ARTICLES

Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor

G Kruppa, B Thoma, T Machleidt, K Wiegmann and M Kronke
Institut fur Medizinische Mikrobiologie und Hygiene, Technische Universitat Munchen, FRG.

The numerous biologic activities of TNF appear mediated by two types of specific cell surface receptors of 55 to 60 kDa (TR55) and 75 to 80 kDa (TR75) molecular mass, respectively. The role of TR55 in the activation of the nuclear transcription factor kappa B (NF-kappa B) was investigated using an antagonistic, mAb, H398, specific for the human TR55. The human leukemic T cell line, Jurkat, which expresses both types of receptors at comparable levels, was used to test for NF-kappa B activation by electrophoretic mobility shift assays using as a probe an oligonucleotide encompassing the two tandemly arranged kappa B sites of the HIV-1 LTR enhancer. mAb H398 is shown to efficiently block not only TNF- but also lymphotoxin-mediated activation of NF-kappa B. Furthermore mAb H398 also impeded TNF- or lymphotoxin-mediated activation of chloramphenicol acetyl transferase gene expression from the HIV-1-LTR as determined by transient transfection assays. These findings indicate that both, induction of NF-kappa B binding to DNA, and transcriptional activity can be efficiently inhibited by selective blockade of TR55. Finally it is shown, that human TR55 confers NF-kappa B inducibility when expressed in the mouse pre-B cell line 70Z/3, which does not respond to TNF in its parental state. Together, the results of this study indicate that TR55 is both necessary and sufficient for mediating TNF activation of NF-kappa B.

This article has been cited by other articles:

				D. Ait-Ali, V. Turquier, Y. Tanguy, E. Thouennon, H. Ghzili, L. Mounien, C. Derambure, S. Jegou, J.-P. Salier, H. Vaudry, et al. Tumor Necrosis Factor (TNF)-{alpha} Persistently Activates Nuclear Factor-{kappa}B Signaling through the Type 2 TNF Receptor in Chromaffin Cells: Implications for Long-Term Regulation of Neuropeptide Gene Expression in Inflammation Endocrinology, June 1, 2008; 149(6): 2840 - 2852. [Abstract] [Full Text] [PDF]

				C. W. Xiao, X. Yan, Y. Li, S. A. G. Reddy, and B. K. Tsang Resistance of Human Ovarian Cancer Cells to Tumor Necrosis Factor {alpha} Is a Consequence of Nuclear Factor {kappa}B-Mediated Induction of Fas-Associated Death Domain-Like Interleukin-1{beta}-Converting Enzyme-Like Inhibitory Protein Endocrinology, February 1, 2003; 144(2): 623 - 630. [Abstract] [Full Text] [PDF]

				C. I. Rodriguez, M. L. Nogal, A. L. Carrascosa, M. L. Salas, M. Fresno, and Y. Revilla African Swine Fever Virus IAP-Like Protein Induces the Activation of Nuclear Factor Kappa B J. Virol., March 19, 2002; 76(8): 3936 - 3942. [Abstract] [Full Text] [PDF]

				T. Iwamoto, S. Fukumoto, K. Kanaoka, E. Sakai, M. Shibata, E. Fukumoto, J.-i. Inokuchi, K. Takamiya, K. Furukawa, K. Furukawa, et al. Lactosylceramide Is Essential for the Osteoclastogenesis Mediated by Macrophage-Colony-stimulating Factor and Receptor Activator of Nuclear Factor-kappa B Ligand J. Biol. Chem., November 30, 2001; 276(49): 46031 - 46038. [Abstract] [Full Text] [PDF]

				T. L. Horn, T. D. O'Brien, L. B. Schook, and M. S. Rutherford Acute Hepatotoxicant Exposure Induces TNFR-Mediated Hepatic Injury and Cytokine/Apoptotic Gene Expression Toxicol. Sci., March 1, 2000; 54(1): 262 - 273. [Abstract] [Full Text] [PDF]

				K. Kobayashi, N. Takahashi, E. Jimi, N. Udagawa, M. Takami, S. Kotake, N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, et al. Tumor Necrosis Factor {alpha} Stimulates Osteoclast Differentiation by a Mechanism Independent of the ODF/RANKL-RANK Interaction J. Exp. Med., January 17, 2000; 191(2): 275 - 286. [Abstract] [Full Text] [PDF]

				X. Hu, M. Tang, A. B. Fisher, N. Olashaw, and K. S. Zuckerman TNF-{alpha}-Induced Growth Suppression of CD34+ Myeloid Leukemic Cell Lines Signals Through TNF Receptor Type I and Is Associated with NF-{kappa}B Activation J. Immunol., September 15, 1999; 163(6): 3106 - 3115. [Abstract] [Full Text] [PDF]

				R. Schwandner, K. Wiegmann, K. Bernardo, D. Kreder, and M. Kronke TNF Receptor Death Domain-associated Proteins TRADD and FADD Signal Activation of Acid Sphingomyelinase J. Biol. Chem., March 6, 1998; 273(10): 5916 - 5922. [Abstract] [Full Text] [PDF]

				Z.-L. Chu, T. A. McKinsey, L. Liu, J. J. Gentry, M. H. Malim, and D. W. Ballard Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappa B control PNAS, September 16, 1997; 94(19): 10057 - 10062. [Abstract] [Full Text] [PDF]

				A. Kalb, H. Bluethmann, M. W. Moore, and W. Lesslauer Tumor Necrosis Factor Receptors (Tnfr) in Mouse Fibroblasts Deficient in Tnfr1 or Tnfr2 are Signaling Competent and Activate the Mitogen-activated Protein Kinase Pathway with Differential Kinetics J. Biol. Chem., November 8, 1996; 271(45): 28097 - 28104. [Abstract] [Full Text] [PDF]

				M. Takeuchi, M. Rothe, and D. V. Goeddel Anatomy of TRAF2. DISTINCT DOMAINS FOR NUCLEAR FACTOR-kappa B ACTIVATION AND ASSOCIATION WITH TUMOR NECROSIS FACTOR SIGNALING PROTEINS J. Biol. Chem., August 16, 1996; 271(33): 19935 - 19942. [Abstract] [Full Text] [PDF]

				D. Adam, K. Wiegmann, S. Adam-Klages, A. Ruff, and M. Kronke A Novel Cytoplasmic Domain of the p55 Tumor Necrosis Factor Receptor Initiates the Neutral Sphingomyelinase Pathway J. Biol. Chem., June 14, 1996; 271(24): 14617 - 14622. [Abstract] [Full Text] [PDF]

				A. Lægreid, L. Thommesen, T. G. Jahr, A. Sundan, and T. Espevik Tumor Necrosis Factor Induces Lipopolysaccharide Tolerance in a Human Adenocarcinoma Cell Line Mainly through the TNF p55 Receptor J. Biol. Chem., October 27, 1995; 270(43): 25418 - 25425. [Abstract] [Full Text] [PDF]

				D. Adam, D. Adam, and M. Krönke Cross-linking of the p55 Tumor Necrosis Factor Receptor Cytoplasmic Domain by a Dimeric Ligand Induces Nuclear Factor-[IMAGE]B and Mediates Cell Death J. Biol. Chem., July 21, 1995; 270(29): 17482 - 17487. [Abstract] [Full Text] [PDF]

				B. Krämer, K. Wiegmann, and M. Krönke Regulation of the Human TNF Promoter by the Transcription Factor Ets J. Biol. Chem., March 24, 1995; 270(12): 6577 - 6583. [Abstract] [Full Text] [PDF]